Celestica, Inc. (NYSE:CLS - Get Free Report) TSE: CLS's share price shot up 2.2% during mid-day trading on Thursday . The company traded as high as $328.58 and last traded at $327.9050. 1,463,032 shares traded hands during mid-day trading, a decline of 41% from the average session volume of 2,476,373 shares. The stock had previously closed at $320.70.
Analyst Ratings Changes
A number of brokerages have issued reports on CLS. Aletheia Capital raised their price target on shares of Celestica from $330.00 to $410.00 and gave the stock a "buy" rating in a report on Tuesday, January 20th. TD Securities raised their price target on shares of Celestica from $305.00 to $330.00 and gave the stock a "hold" rating in a report on Friday, January 30th. TD Cowen reissued a "hold" rating on shares of Celestica in a report on Friday, January 30th. Barclays raised their price target on shares of Celestica from $359.00 to $391.00 and gave the stock an "overweight" rating in a report on Friday, January 30th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $400.00 price objective on shares of Celestica in a research report on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $355.39.
Get Our Latest Stock Analysis on Celestica
Celestica Trading Up 2.2%
The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.88 and a current ratio of 1.44. The stock's 50-day simple moving average is $283.79 and its 200-day simple moving average is $294.02. The firm has a market capitalization of $37.70 billion, a PE ratio of 45.67 and a beta of 1.88.
Insider Buying and Selling at Celestica
In other Celestica news, insider Yann L. Etienvre sold 86,229 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $287.45, for a total transaction of $24,786,526.05. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, President Todd C. Cooper sold 89,484 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $287.45, for a total transaction of $25,722,175.80. Following the transaction, the president directly owned 108,970 shares in the company, valued at approximately $31,323,426.50. The trade was a 45.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 297,923 shares of company stock valued at $88,027,459. 0.52% of the stock is currently owned by company insiders.
Institutional Trading of Celestica
A number of hedge funds and other institutional investors have recently modified their holdings of CLS. Allianz Asset Management GmbH lifted its stake in shares of Celestica by 7.3% in the 3rd quarter. Allianz Asset Management GmbH now owns 337,397 shares of the technology company's stock worth $83,044,000 after purchasing an additional 22,863 shares during the period. Spark Investment Management LLC lifted its stake in shares of Celestica by 17.4% in the 3rd quarter. Spark Investment Management LLC now owns 27,000 shares of the technology company's stock worth $6,643,000 after purchasing an additional 4,000 shares during the period. Light Street Capital Management LLC bought a new position in shares of Celestica in the 2nd quarter worth approximately $26,422,000. William Blair Investment Management LLC bought a new position in shares of Celestica in the 3rd quarter worth approximately $28,924,000. Finally, Spire Wealth Management lifted its stake in shares of Celestica by 354.3% in the 4th quarter. Spire Wealth Management now owns 5,979 shares of the technology company's stock worth $1,767,000 after purchasing an additional 4,663 shares during the period. 67.38% of the stock is owned by hedge funds and other institutional investors.
About Celestica
(
Get Free Report)
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.